Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 55Pancreatic Neoplasms 14Colorectal Neoplasms 6Neoplasm Metastasis 5Esophageal Squamous Cell Carcinoma 5Esophageal Neoplasms 4Biliary Tract Neoplasms 4Advanced Pancreatic Cancer 3Stage IV Gastric Cancer With Metastasis 2Recurrence 2Rectal Neoplasms 2Locally Advanced Pancreatic Cancer 2Head and Neck Neoplasms 2Gastrointestinal Neoplasms 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Advanced Gastric Cancer 2mCRC 1Surgically-Created Resection Cavity 1Radiation Injuries 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Ductal Adenocarcinoma 1Non-small Cell Lung Cancer Stage â…¡ 1Nasopharyngeal Carcinoma 1NSCLC 1Metastatic Gastric Adenocarcinoma 1Lung Neoplasms 1HER2-positive 1HER-2 Negatived Gastric Cancer 1Gastric Cancer With Positive Exfoliative Cancer Cells 1

Interventions

camrelizumab 2spartalizumab 1apatinib 1S 1 (combination) 1Neoadjuvant Therapy 1Hyperthermic Intraperitoneal Chemotherapy 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Advanced Gastric Adenocarcinoma × S 1 (combination) × Clear all
NCT04675866 2022-04-15

Camrelizumab Combined With Albumin-bound Paclitaxel and S-1 in the Treatment of Advanced Gastric Cancer

Henan Cancer Hospital

Phase NA Unknown
46 enrolled
Gastrointestinal

Advanced Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡